UBAP1 p.Gln422Arg
c.1265A>G · rs1227081826 · VCV1679276
Computational evidence
| Protein change | ||
| AlphaMissense | 0.238 | likely benign ⚠ discordant with ClinVar |
|---|---|---|
| REVEL | 0.41 | indeterminate |
| SaProt | LLR -5.97 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.87 | unconstrained · MANE · 9,962 bp · p 0.0098 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,227 |
| South Asiangrpmax | 0.0011% | 91,066 |
| European (non-Finnish) | 0.00102% | 98,332 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- UBAP1
- Protein
- p.Gln422Arg
- Coding
- c.1265A>G
- MANE Select
- NM_016525
- dbSNP
- rs1227081826
- Type
- single nucleotide variant
- Location
- chr9:34249960 (GRCh38)
- Gene constraint
- LOEUF 0.285 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 63.60 · 3 PDB
- Residue 422
- a UniProt-annotated variant site (in spg80); a UniProt-annotated variant site (in spg80; uncertain significance); the uba 1 domain; an α-helix
Disease context
spastic paraplegia 80, autosomal dominant — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autosomal dominant spastic paraplegia type 80 (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Childhood
Similar variants
- UBAP1 c.-20C>T Likely pathogenic ★ same condition
- UBAP1 p.Glu160Ter Likely pathogenic ★ same condition
- UBAP1 p.Glu163Ter Likely pathogenic ★ same condition
- UBAP1 p.Glu179Ter Pathogenic ★ same condition
- UBAP1 p.Gly7Ter Likely pathogenic ★ same condition
- UBAP1 p.Lys106Ter Pathogenic ★ same condition
- UBAP1 p.Arg9Trp Conflicting classifications of pathogenicity ★ same condition
- UBAP1 p.Glu418Lys Conflicting classifications of pathogenicity ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ubap1-p-gln422arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown